Investments in and Advances to Unconsolidated Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2017

Investments in and Advances to Unconsolidated Joint Ventures

Company owned interests in entities, accounted under equity method (dollars in thousands)

The Company owns interests in the following entities that are accounted for under the equity method at March 31, 2017 (dollars in thousands):

					Carrying Amount
					March 31,		December 31,
Entity(1)	Segment	Ownership%			2017		2016
CCRC JV(2)	SHOP		49		$	434,649	$	439,449
RIDEA II(6)	SHOP		40			263,180		—
HCP Life Science(4)	Life science	50	–	63		65,490		67,879
MBK JV(3)	SHOP		50			39,088		38,909
HCP Ventures IV, LLC	Medical office		20			7,338		7,277
Vintage Park Development JV	SHOP		85			6,953		7,486
Suburban Properties, LLC	Medical office		67			4,618		4,628
MBK Development JV(3)	SHOP		50			2,464		2,463
K&Y(5)	Other non-reportable segments		80			1,380		1,342
Advances to unconsolidated JVs, net and other						2,042		2,058
					$	827,202	$	571,491

(1) These entities are not consolidated because the Company does not control, through voting rights or other means, the JVs.

(2) Includes two unconsolidated JVs in a RIDEA structure (CCRC PropCo and CCRC OpCo).

(3) Includes two unconsolidated JVs in a RIDEA structure.

(4) Includes the following unconsolidated partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%) and (iii) LASDK, LP (63%).

(5) Includes three unconsolidated JVs.

(6) Includes three unconsolidated JVs in a RIDEA structure (HCP/CPA PropCo, HCP/CPA OpCo, and RIDEA II PropCo).

See Note 4 for further information on the deconsolidation of RIDEA II.